RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ana M. Espino to Animals

This is a "connection" page, showing publications Ana M. Espino has written about Animals.
Connection Strength

1.017
  1. Valdes-Fernandez BN, Ruiz-Jimenez C, Armina-Rodriguez A, Mendez LB, Espino AM. Fasciola hepatica GST mu-class suppresses the cytokine storm induced by E. coli-lipopolysaccharide, whereas it modulates the dynamic of peritoneal macrophages in a mouse model and suppresses the classical activation of macrophages. Microbiol Spectr. 2024 Jan 11; 12(1):e0347523.
    View in: PubMed
    Score: 0.072
  2. Ruiz-Jim?nez C, Celias D, Vald?s B, Ramos-P?rez WD, Cervi L, Espino AM. Fasciola hepatica fatty acid binding protein (Fh12) induces apoptosis and tolerogenic properties in murine bone marrow derived dendritic cells. Exp Parasitol. 2021 Dec; 231:108174.
    View in: PubMed
    Score: 0.062
  3. Figueroa-Santiago O, Espino A. Purification of Native Fasciola hepatica Fatty Acid-Binding Protein and Induction of Alternative Activation of Human Macrophages. Methods Mol Biol. 2020; 2137:149-169.
    View in: PubMed
    Score: 0.055
  4. Figueroa-Santiago O, Espino A. Possible Role for Toll-Like Receptors in Interaction of Fasciola hepatica Excretory-Secretory Products with Human Monocyte Cell Line. Methods Mol Biol. 2020; 2137:171-180.
    View in: PubMed
    Score: 0.055
  5. Aguayo V, Vald?s Fernandez BN, Rodr?guez-Valent?n M, Ruiz-Jim?nez C, Ramos-Ben?tez MJ, M?ndez LB, Espino AM. Fasciola hepatica GST downregulates NF-?B pathway effectors and inflammatory cytokines while promoting survival in a mouse septic shock model. Sci Rep. 2019 02 19; 9(1):2275.
    View in: PubMed
    Score: 0.052
  6. Ramos-Benitez MJ, Ruiz-Jimenez C, Rosado-Franco JJ, Ramos-P?rez WD, Mendez LB, Osuna A, Espino AM. Fh15 Blocks the Lipopolysaccharide-Induced Cytokine Storm While Modulating Peritoneal Macrophage Migration and CD38 Expression within Spleen Macrophages in a Mouse Model of Septic Shock. mSphere. 2018 12 19; 3(6).
    View in: PubMed
    Score: 0.051
  7. Ramos-Ben?tez MJ, Lopez-Cruz LM, Aguayo V, Ruiz-Jimenez C, Espino AM. Cell-free expression, purification and immunoreactivity assessment of recombinant Fasciola hepatica saposin-like protein-2. Mol Biol Rep. 2018 Oct; 45(5):1551-1556.
    View in: PubMed
    Score: 0.050
  8. Aguayo V, Valdes B, Espino AM. Assessment of Fasciola hepatica glutathione S-transferase as an antigen for serodiagnosis of human chronic fascioliasis. Acta Trop. 2018 Oct; 186:41-49.
    View in: PubMed
    Score: 0.050
  9. Ramos-Ben?tez MJ, Ruiz-Jim?nez C, Aguayo V, Espino AM. Recombinant Fasciola hepatica fatty acid binding protein suppresses toll-like receptor stimulation in response to multiple bacterial ligands. Sci Rep. 2017 07 14; 7(1):5455.
    View in: PubMed
    Score: 0.046
  10. Rivera F, Espino AM. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica. Exp Parasitol. 2016 Jan; 160:31-8.
    View in: PubMed
    Score: 0.041
  11. Martin I, Cab?n-Hern?ndez K, Figueroa-Santiago O, Espino AM. Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo. J Immunol. 2015 Apr 15; 194(8):3924-36.
    View in: PubMed
    Score: 0.039
  12. Figueroa-Santiago O, Espino AM. Fasciola hepatica fatty acid binding protein induces the alternative activation of human macrophages. Infect Immun. 2014 Dec; 82(12):5005-12.
    View in: PubMed
    Score: 0.038
  13. Cab?n-Hern?ndez K, Gaudier JF, Ruiz-Jim?nez C, Espino AM. Development of two antibody detection enzyme-linked immunosorbent assays for serodiagnosis of human chronic fascioliasis. J Clin Microbiol. 2014 Mar; 52(3):766-72.
    View in: PubMed
    Score: 0.036
  14. Cab?n-Hern?ndez K, Espino AM. Differential expression and localization of saposin-like protein 2 of Fasciola hepatica. Acta Trop. 2013 Dec; 128(3):591-7.
    View in: PubMed
    Score: 0.035
  15. Morales A, Espino AM. Evaluation and characterization of Fasciola hepatica tegument protein extract for serodiagnosis of human fascioliasis. Clin Vaccine Immunol. 2012 Nov; 19(11):1870-8.
    View in: PubMed
    Score: 0.033
  16. Gaudier JF, Cab?n-Hern?ndez K, Osuna A, Espino AM. Biochemical characterization and differential expression of a 16.5-kilodalton tegument-associated antigen from the liver fluke Fasciola hepatica. Clin Vaccine Immunol. 2012 Mar; 19(3):325-33.
    View in: PubMed
    Score: 0.032
  17. Cab?n-Hern?ndez K, Gaudier JF, Espino AM. Characterization and differential expression of a ferritin protein from Fasciola hepatica. Mol Biochem Parasitol. 2012 Mar-Apr; 182(1-2):54-61.
    View in: PubMed
    Score: 0.032
  18. Figueroa-Santiago O, Delgado B, Espino AM. Fasciola hepatica saposin-like protein-2-based ELISA for the serodiagnosis of chronic human fascioliasis. Diagn Microbiol Infect Dis. 2011 Jul; 70(3):355-61.
    View in: PubMed
    Score: 0.030
  19. Boukli NM, Delgado B, Ricaurte M, Espino AM. Fasciola hepatica and Schistosoma mansoni: identification of common proteins by comparative proteomic analysis. J Parasitol. 2011 Oct; 97(5):852-61.
    View in: PubMed
    Score: 0.030
  20. Espino AM, Morales A, Delgado B, Rivera FM, Figueroa O, Su?rez E. Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct. Ethn Dis. 2010; 20(1 Suppl 1):S1-17-23.
    View in: PubMed
    Score: 0.027
  21. Espino AM, Rivera F. Quantitation of cytokine mRNA by real-time RT-PCR during a vaccination trial in a rabbit model of fascioliasis. Vet Parasitol. 2010 Apr 19; 169(1-2):82-92.
    View in: PubMed
    Score: 0.027
  22. Espino AM, Torres D, Morales A, Delgado B, Quetel J, Osuna A. Fasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5 kDa saposin-like protein SAP-2 using synthetic peptides. Exp Parasitol. 2007 Sep; 117(1):65-73.
    View in: PubMed
    Score: 0.023
  23. Torres D, Espino AM. Mapping of B-cell epitopes on a novel 11.5-kilodalton Fasciola hepatica-Schistosoma mansoni cross-reactive antigen belonging to a member of the F. hepatica saposin-like protein family. Infect Immun. 2006 Aug; 74(8):4932-8.
    View in: PubMed
    Score: 0.022
  24. Espino AM, Osuna A, Gil R, Hillyer GV. Fasciola hepatica: humoral and cytokine responses to a member of the saposin-like protein family following delivery as a DNA vaccine in mice. Exp Parasitol. 2005 Aug; 110(4):374-83.
    View in: PubMed
    Score: 0.020
  25. Espino AM, Hillyer GV. A novel Fasciola hepatica saposinlike recombinant protein with immunoprophylactic potential. J Parasitol. 2004 Aug; 90(4):876-9.
    View in: PubMed
    Score: 0.019
  26. Espino AM, Hillyer GV. Molecular cloning of a member of the Fasciola hepatica saposin-like protein family. J Parasitol. 2003 Jun; 89(3):545-52.
    View in: PubMed
    Score: 0.017
  27. Shin SH, Hsu A, Chastain HM, Cruz LA, Elder ES, Sapp SG, McAuliffe I, Espino AM, Handali S. Development of Two FhSAP2 Recombinant-Based Assays for Immunodiagnosis of Human Chronic Fascioliasis. Am J Trop Med Hyg. 2016 Oct 05; 95(4):852-855.
    View in: PubMed
    Score: 0.011
  28. De Pablos LM, D?az Lozano IM, Jercic MI, Quinzada M, Gim?nez MJ, Calabuig E, Espino AM, Schijman AG, Zulantay I, Apt W, Osuna A. The C-terminal region of Trypanosoma cruzi MASPs is antigenic and secreted via exovesicles. Sci Rep. 2016 06 08; 6:27293.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support